Home > Insider Trading > Filing (0001209191-20-031000)

Filing Details

Accession Number:: 0001209191-20-031000
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-05-20 18:07:15
Reporting Period:: 2020-05-18

Accepted Time:: 2020-05-20 18:07:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1564824	Allakos Inc.	ALLK	Pharmaceutical Preparations (2834)	454798831

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1674884	A Peter Hudson	One Embarcadero Center Suite 3700 San Francisco CA 94111		No	No	No	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-05-18	4,549	$71.13	6,989	No	4	S	Indirect	By Hudson Capital LLC
Common Stock	Disposition	2020-05-18	6,989	$72.33	0	No	4	S	Indirect	By Hudson Capital LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Hudson Capital LLC
No	4	S	Indirect	By Hudson Capital LLC

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,557,377	Indirect	See Footnote

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.72 - $71.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
These shares are owned by Hudson Capital, LLC, a limited liability company of which the Reporting Person is the managing member. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.83 - $72.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
These shares are directly held by Alta Partners NextGen Fund I L.P. ("APNG I"). Alta Partners NextGen Fund I Management, LLC ("APNG I Management") is the general partner of APNG I. The Reporting Person is one of three managing directors of APNG I Management and, as such, has voting and investment control with respect to the shares held by APNG I. The Reporting Person disclaims beneficial ownership of all shares held by APNG I, except to the extent of his pecuniary interest therein.